Bristol-Myers Squibb Co vs Dover Corp — how do they compare? Bristol-Myers Squibb Co trades at $64.69 (market cap $130.12B), while Dover Corp trades at $206.38 (market cap $28.02B). The key difference: Bristol-Myers Squibb Co is far larger — about 4.6× Dover Corp's market cap, and Bristol-Myers Squibb Co pays the higher dividend (3.96%). Which is the better fit depends on your goals.
| BMY | DOV | |
|---|---|---|
Market Cap | $130.12B | $28.02B |
Sector | Health | Industrials |
52-Week High | $65.89 | $233.31 |
52-Week Low | $42.60 | $161.16 |
Enterprise Value | $164.11B | $29.53B |
Dividend Yield | 3.96% | 1.01% |
Trailing returns across standard periods
Latest headlines on both assets
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.
Read more on DOV →